26 results
SC 13D/A
EX-3
10X Fund, L.P.
1 Dec 23
GALECTIN THERAPEUTICS / 10X Fund ownership change
4:38pm
10-K
2022 FY
EX-3.7
GALT
Galectin Therapeutics Inc
Annual report
30 Mar 23
7:52am
8-K
EX-3.2
GALT
Galectin Therapeutics Inc
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
GALT
Galectin Therapeutics Inc
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.3
GALT
Galectin Therapeutics Inc
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
ckmxyb0 rhwpip
17 Feb 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
q5xkfnz4wz3
27 Sep 16
Galectin Therapeutics Announces Top-Line Data from Exploratory Phase 2a Pilot Trial (NASH-FX) with GR-MD-02 in NASH Patients with Advanced Fibrosis
12:00am
8-K
EX-3.1
2yq4ih31
30 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.2
nvvwtc3ek7
30 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.1
ax3c3w2xmp5
23 Mar 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.2
3vwt20g k8
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.3
jhgozhf5
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.1
ttj4seq 0f4jfh
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.1
jv0htqlz2d8r9pe1e nw
27 Jan 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
pt3d0hpr0f492cz00ex
6 Jan 11
Pro-pharmaceuticals Closes $2.1 Million Offering
12:00am
8-K
EX-3.1
kvgc jddo
17 Feb 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
ljw60dvna2vqadcah5gu
28 May 09
Departure of Directors or Certain Officers
12:00am